FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948506085> ?p ?o ?g. }

• W2948506085 abstract "Abstract Background In 2014, an outbreak of adenoviral pneumonia occurred in the Korean military training center. However, there are limited data on the characteristics of the fever and its response to antipyretic therapy in immunocompetent adults with adenovirus-positive community-acquired pneumonia (CAP). Methods The medical records of the patients who were admitted to the Armed Forces Chuncheon Hospital for the treatment of CAP between January 2014 and December 2016 were retrospectively analyzed. The patients were divided into three groups, namely, the adenovirus-positive (Adv) group, the adenovirus-negative (Non-Adv) group and the unknown pathogen group, according to the results of a polymerase chain reaction (PCR) test and sputum culture used to measure adenovirus and other bacteria or viruses in respiratory specimens. We evaluated and compared the demographics, clinicolaboratory findings and radiological findings upon admission between the two groups. Results Out of the 251 military personnel with CAP during the study periods, 67 were classified into the Adv group, while 134 were classified into the Non-Adv group and 50 were classified into the unknown pathogen group. The patients in the Adv group had a longer duration of fever after admission (3.2 ± 1.6 vs. 1.9 ± 1.2 vs. 2.2 ± 1.5 days, P = 0.018) and symptom onset (5.8 ± 2.2 vs. 3.9 ± 2.5 vs. 3.7 ± 2.0 days, P = 0.006) than patients in the Non-Adv and unknown pathogen groups, respectively. The patients in the Adv group had a higher mean temperature at admission (37.8 ± 0.3 vs. 37.3 ± 0.3 vs. 37.3 ± 0.3, P = 0.005), and more patients were observed over 40 and 39 to 40(14.9% vs. 2.2% vs. 4.0%, 35.8% vs. 3.7% vs. 6.0%, P < 0.001) than those in the Non-Adv and unknown pathogen groups, respectively. The Adv group more commonly had no response or exhibited adverse events after antipyretic treatment compared to the Non-Adv group (17.9% vs. 1.5%, 35.0% vs. 4.3%, P < 0.001, P = 0.05, respectively). In addition, the time from admission to overall clinical stabilization was significantly longer in the patients in the Adv group than in those in the Non-Adv group (4.3 ± 2.8 vs. 2.9 ± 1.8 days, P = 0.034, respectively). Furthermore, no significant difference in the length of hospital stay was observed between the two groups, and no patient died in either group. Conclusion In this study, Adv-positive CAP in immunocompetent military personnel patients had distinct fever characteristics and responses to antipyretic treatment." @default.
• W2948506085 created "2019-06-14" @default.
• W2948506085 creator A5038038620 @default.
• W2948506085 creator A5082822820 @default.
• W2948506085 creator A5088688292 @default.
• W2948506085 date "2020-02-21" @default.
• W2948506085 modified "2023-10-14" @default.
• W2948506085 title "Characteristics of fever and response to antipyretic therapy in military personnel with adenovirus-positive community-acquired pneumonia" @default.
• W2948506085 cites W1200773213 @default.
• W2948506085 cites W1441570733 @default.
• W2948506085 cites W1968500772 @default.
• W2948506085 cites W1973344606 @default.
• W2948506085 cites W1986193680 @default.
• W2948506085 cites W2028546537 @default.
• W2948506085 cites W2035353742 @default.
• W2948506085 cites W2036802414 @default.
• W2948506085 cites W2055242542 @default.
• W2948506085 cites W2092624283 @default.
• W2948506085 cites W2102079840 @default.
• W2948506085 cites W2133979383 @default.
• W2948506085 cites W2173377491 @default.
• W2948506085 cites W2441125707 @default.
• W2948506085 cites W2487775023 @default.
• W2948506085 cites W2510793492 @default.
• W2948506085 cites W2512123337 @default.
• W2948506085 cites W2560615979 @default.
• W2948506085 cites W2577628934 @default.
• W2948506085 cites W2581794847 @default.
• W2948506085 cites W2606926125 @default.
• W2948506085 cites W4240713867 @default.
• W2948506085 doi "https://doi.org/10.1186/s40779-020-00235-x" @default.
• W2948506085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7033854" @default.
• W2948506085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32079545" @default.
• W2948506085 hasPublicationYear "2020" @default.
• W2948506085 type Work @default.
• W2948506085 sameAs 2948506085 @default.
• W2948506085 citedByCount "3" @default.
• W2948506085 countsByYear W29485060852020 @default.
• W2948506085 countsByYear W29485060852021 @default.
• W2948506085 countsByYear W29485060852023 @default.
• W2948506085 crossrefType "journal-article" @default.
• W2948506085 hasAuthorship W2948506085A5038038620 @default.
• W2948506085 hasAuthorship W2948506085A5082822820 @default.
• W2948506085 hasAuthorship W2948506085A5088688292 @default.
• W2948506085 hasBestOaLocation W29485060851 @default.
• W2948506085 hasConcept C116675565 @default.
• W2948506085 hasConcept C126322002 @default.
• W2948506085 hasConcept C142724271 @default.
• W2948506085 hasConcept C159047783 @default.
• W2948506085 hasConcept C203014093 @default.
• W2948506085 hasConcept C2776102371 @default.
• W2948506085 hasConcept C2776301714 @default.
• W2948506085 hasConcept C2776460866 @default.
• W2948506085 hasConcept C2777914695 @default.
• W2948506085 hasConcept C2779252780 @default.
• W2948506085 hasConcept C2780820201 @default.
• W2948506085 hasConcept C2781069245 @default.
• W2948506085 hasConcept C42219234 @default.
• W2948506085 hasConcept C71924100 @default.
• W2948506085 hasConcept C90924648 @default.
• W2948506085 hasConceptScore W2948506085C116675565 @default.
• W2948506085 hasConceptScore W2948506085C126322002 @default.
• W2948506085 hasConceptScore W2948506085C142724271 @default.
• W2948506085 hasConceptScore W2948506085C159047783 @default.
• W2948506085 hasConceptScore W2948506085C203014093 @default.
• W2948506085 hasConceptScore W2948506085C2776102371 @default.
• W2948506085 hasConceptScore W2948506085C2776301714 @default.
• W2948506085 hasConceptScore W2948506085C2776460866 @default.
• W2948506085 hasConceptScore W2948506085C2777914695 @default.
• W2948506085 hasConceptScore W2948506085C2779252780 @default.
• W2948506085 hasConceptScore W2948506085C2780820201 @default.
• W2948506085 hasConceptScore W2948506085C2781069245 @default.
• W2948506085 hasConceptScore W2948506085C42219234 @default.
• W2948506085 hasConceptScore W2948506085C71924100 @default.
• W2948506085 hasConceptScore W2948506085C90924648 @default.
• W2948506085 hasIssue "1" @default.
• W2948506085 hasLocation W29485060851 @default.
• W2948506085 hasLocation W29485060852 @default.
• W2948506085 hasLocation W29485060853 @default.
• W2948506085 hasLocation W29485060854 @default.
• W2948506085 hasOpenAccess W2948506085 @default.
• W2948506085 hasPrimaryLocation W29485060851 @default.
• W2948506085 hasRelatedWork W2042282896 @default.
• W2948506085 hasRelatedWork W2088855007 @default.
• W2948506085 hasRelatedWork W2106610500 @default.
• W2948506085 hasRelatedWork W2353587999 @default.
• W2948506085 hasRelatedWork W2357843741 @default.
• W2948506085 hasRelatedWork W2362256731 @default.
• W2948506085 hasRelatedWork W2415122566 @default.
• W2948506085 hasRelatedWork W3043242438 @default.
• W2948506085 hasRelatedWork W4213449541 @default.
• W2948506085 hasRelatedWork W2741166418 @default.
• W2948506085 hasVolume "7" @default.
• W2948506085 isParatext "false" @default.
• W2948506085 isRetracted "false" @default.
• W2948506085 magId "2948506085" @default.
• W2948506085 workType "article" @default.